ACCESSION: MSBNK-SMB_Measured-HSA001P0157008
RECORD_TITLE: Characterized; 3-piperazin-1-ylpropanenitrile; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 222
COMMENT: RAW_SPEC {'BLK02_740': {'bp': 2554039.0, 'sum': 5483974.0}, '4_posi_1280': {'bp': 313551.0, 'sum': 923416.0}, '16_posi_1133': {'bp': 420652.0, 'sum': 1148947.0}, '4_posi_1364': {'bp': 423307.0, 'sum': 1139986.0}, '18_posi_920': {'bp': 434894.0, 'sum': 1168961.0}, '10_posi_1111': {'bp': 437517.0, 'sum': 1139975.0}, '10_posi_1405': {'bp': 457817.0, 'sum': 1192290.0}, '7_posi_1154': {'bp': 498417.0, 'sum': 1240168.0}, '11_posi_375': {'bp': 513026.0, 'sum': 1335927.0}, '11_posi_81': {'bp': 525560.0, 'sum': 1388628.0}, '3_posi_1152': {'bp': 540192.0, 'sum': 1331163.0}, '4_posi_1111': {'bp': 541592.0, 'sum': 1316968.0}, '10_posi_80': {'bp': 569164.0, 'sum': 1517750.0}, '10_posi_334': {'bp': 655965.0, 'sum': 1627812.0}, '4_posi_78': {'bp': 676137.0, 'sum': 1744105.0}, '2_posi_167': {'bp': 685784.0, 'sum': 1720336.0}, '3_posi_271': {'bp': 691007.0, 'sum': 1706788.0}, '3_posi_900': {'bp': 777424.0, 'sum': 1699748.0}, '18_posi_838': {'bp': 788541.0, 'sum': 1779830.0}, '4_posi_595': {'bp': 1056580.0, 'sum': 2152071.0}, '1_posi_593': {'bp': 1227824.0, 'sum': 2506167.0}, '2_posi_823': {'bp': 1295244.0, 'sum': 2588487.0}, '5_posi_800': {'bp': 1302938.0, 'sum': 2547584.0}, '12_posi_761': {'bp': 1611633.0, 'sum': 3541274.0}, '15_posi_1489': {'bp': 354715.0, 'sum': 1002485.0}, '8_posi_1406': {'bp': 417230.0, 'sum': 1087701.0}, '13_posi_1109': {'bp': 426081.0, 'sum': 1117020.0}, '15_posi_1007': {'bp': 431289.0, 'sum': 1167917.0}, '12_posi_1028': {'bp': 441894.0, 'sum': 1161845.0}, '1_posi_1217': {'bp': 451955.0, 'sum': 1228937.0}, '10_posi_1023': {'bp': 472217.0, 'sum': 1228766.0}, 'ProcedureBlank_1194': {'bp': 488128.0, 'sum': 1206080.0}, '9_posi_78': {'bp': 489234.0, 'sum': 1296605.0}, 'ProcedureBlank_1488': {'bp': 496241.0, 'sum': 1269069.0}, '8_posi_1070': {'bp': 503224.0, 'sum': 1261565.0}, '14_posi_81': {'bp': 515815.0, 'sum': 1402653.0}, '15_posi_314': {'bp': 519179.0, 'sum': 1410289.0}, '12_posi_164': {'bp': 526442.0, 'sum': 1419227.0}, '14_posi_353': {'bp': 530583.0, 'sum': 1430613.0}, '7_posi_712': {'bp': 557205.0, 'sum': 1337683.0}, '12_posi_419': {'bp': 576921.0, 'sum': 1460571.0}, '3_posi_979': {'bp': 584623.0, 'sum': 1398343.0}, '3_posi_689': {'bp': 584732.0, 'sum': 1363747.0}, '5_posi_80': {'bp': 587686.0, 'sum': 1492932.0}, '12_posi_78': {'bp': 637425.0, 'sum': 1636762.0}, '6_posi_335': {'bp': 639878.0, 'sum': 1514924.0}, '15_posi_881': {'bp': 653972.0, 'sum': 1464908.0}, '12_posi_900': {'bp': 685036.0, 'sum': 1542890.0}, '5_posi_880': {'bp': 688994.0, 'sum': 1541571.0}, '1_posi_166': {'bp': 719066.0, 'sum': 1713088.0}, '2_posi_251': {'bp': 732253.0, 'sum': 1734880.0}, '1_posi_247': {'bp': 750472.0, 'sum': 1802912.0}, 'BLK02_1027': {'bp': 763321.0, 'sum': 1825305.0}, '4_posi_863': {'bp': 834042.0, 'sum': 1826708.0}, 'ProcedureBlank_79': {'bp': 834520.0, 'sum': 1937260.0}, '1_posi_61': {'bp': 860965.0, 'sum': 2033793.0}, '16_posi_826': {'bp': 982196.0, 'sum': 2012936.0}, '11_posi_822': {'bp': 1027702.0, 'sum': 2089608.0}, '1_posi_844': {'bp': 1045896.0, 'sum': 2159282.0}, '7_posi_843': {'bp': 1048814.0, 'sum': 2112415.0}, '5_posi_595': {'bp': 1163057.0, 'sum': 2397428.0}, '8_posi_825': {'bp': 1201963.0, 'sum': 2413748.0}, '17_posi_824': {'bp': 1234340.0, 'sum': 2458847.0}, '3_posi_594': {'bp': 1255324.0, 'sum': 2520298.0}, '9_posi_595': {'bp': 1296741.0, 'sum': 2649692.0}, '4_posi_800': {'bp': 1350772.0, 'sum': 2674612.0}, '10_posi_799': {'bp': 1397317.0, 'sum': 2790919.0}, '7_posi_781': {'bp': 1449576.0, 'sum': 2963272.0}, '17_posi_763': {'bp': 1519712.0, 'sum': 3436557.0}, '9_posi_1423': {'bp': 398717.0, 'sum': 1124521.0}, '12_posi_1191': {'bp': 400748.0, 'sum': 1096686.0}, '16_posi_125': {'bp': 424878.0, 'sum': 1255361.0}, '9_posi_1091': {'bp': 474369.0, 'sum': 1233753.0}, '3_posi_1468': {'bp': 489359.0, 'sum': 1284143.0}, '1_posi_1385': {'bp': 498069.0, 'sum': 1285705.0}, '1_posi_1131': {'bp': 520482.0, 'sum': 1317893.0}, '4_posi_940': {'bp': 527202.0, 'sum': 1250752.0}, '11_posi_207': {'bp': 539460.0, 'sum': 1420666.0}, '2_posi_984': {'bp': 611638.0, 'sum': 1475509.0}, 'BLK02_1383': {'bp': 621247.0, 'sum': 1613310.0}, '6_posi_162': {'bp': 624669.0, 'sum': 1552966.0}, '6_posi_246': {'bp': 625266.0, 'sum': 1574843.0}, '7_posi_81': {'bp': 636743.0, 'sum': 1597061.0}, '1_posi_922': {'bp': 654823.0, 'sum': 1530096.0}, '2_posi_691': {'bp': 667279.0, 'sum': 1543047.0}, 'BLK02_335': {'bp': 903054.0, 'sum': 2158111.0}, '15_posi_799': {'bp': 1158961.0, 'sum': 2338510.0}, '12_posi_823': {'bp': 1210748.0, 'sum': 2377959.0}, '7_posi_592': {'bp': 1233392.0, 'sum': 2536129.0}, '3_posi_823': {'bp': 1330515.0, 'sum': 2556566.0}, '14_posi_741': {'bp': 1497786.0, 'sum': 3664451.0}, '10_posi_741': {'bp': 1827483.0, 'sum': 4512966.0}, '2_posi_760': {'bp': 1867052.0, 'sum': 3816663.0}, '6_posi_1427': {'bp': 400511.0, 'sum': 1074457.0}, '14_posi_986': {'bp': 430620.0, 'sum': 1166147.0}, '17_posi_81': {'bp': 485395.0, 'sum': 1378804.0}, '3_posi_1381': {'bp': 500551.0, 'sum': 1271570.0}, '9_posi_166': {'bp': 508522.0, 'sum': 1363653.0}, '7_posi_1068': {'bp': 515477.0, 'sum': 1283018.0}, '10_posi_943': {'bp': 560262.0, 'sum': 1337100.0}, '8_posi_289': {'bp': 575572.0, 'sum': 1446886.0}, '13_posi_83': {'bp': 577541.0, 'sum': 1480533.0}, '2_posi_1091': {'bp': 605094.0, 'sum': 1419982.0}, '10_posi_207': {'bp': 613062.0, 'sum': 1578466.0}, '6_posi_82': {'bp': 637460.0, 'sum': 1601061.0}, '2_posi_335': {'bp': 746090.0, 'sum': 1721311.0}, '3_posi_82': {'bp': 759747.0, 'sum': 1829129.0}, '2_posi_75': {'bp': 778698.0, 'sum': 1885219.0}, '13_posi_733': {'bp': 1100869.0, 'sum': 2633842.0}, '9_posi_825': {'bp': 1157940.0, 'sum': 2381280.0}, '8_posi_592': {'bp': 1170420.0, 'sum': 2457040.0}, '18_posi_763': {'bp': 1212415.0, 'sum': 3233744.0}, '12_posi_593': {'bp': 1255608.0, 'sum': 2712958.0}, '11_posi_762': {'bp': 1610789.0, 'sum': 3580731.0}, '14_posi_1175': {'bp': 397317.0, 'sum': 1114292.0}, '10_posi_1196': {'bp': 401440.0, 'sum': 1094648.0}, '16_posi_227': {'bp': 432257.0, 'sum': 1286552.0}, '14_posi_249': {'bp': 508175.0, 'sum': 1338900.0}, '1_posi_1027': {'bp': 539811.0, 'sum': 1302279.0}, '9_posi_923': {'bp': 541021.0, 'sum': 1275259.0}, '9_posi_270': {'bp': 552723.0, 'sum': 1457014.0}, '14_posi_901': {'bp': 613830.0, 'sum': 1434160.0}, '7_posi_166': {'bp': 635255.0, 'sum': 1541351.0}, '11_posi_901': {'bp': 641452.0, 'sum': 1478592.0}, '8_posi_78': {'bp': 680632.0, 'sum': 1661944.0}, '3_posi_185': {'bp': 719416.0, 'sum': 1806822.0}, '10_posi_862': {'bp': 921340.0, 'sum': 1954950.0}, '10_posi_594': {'bp': 1199619.0, 'sum': 2504032.0}, '14_posi_799': {'bp': 1211068.0, 'sum': 2481368.0}, '16_posi_763': {'bp': 1337759.0, 'sum': 3037886.0}, '11_posi_1469': {'bp': 377933.0, 'sum': 1097192.0}, '15_posi_186': {'bp': 523437.0, 'sum': 1382141.0}, '8_posi_962': {'bp': 535312.0, 'sum': 1354276.0}, '14_posi_167': {'bp': 554147.0, 'sum': 1476650.0}, '8_posi_692': {'bp': 557771.0, 'sum': 1395144.0}, '8_posi_373': {'bp': 566625.0, 'sum': 1455929.0}, '5_posi_163': {'bp': 567911.0, 'sum': 1442689.0}, '7_posi_920': {'bp': 593215.0, 'sum': 1378763.0}, '8_posi_763': {'bp': 1616144.0, 'sum': 3313578.0}, '9_posi_763': {'bp': 1635448.0, 'sum': 3412847.0}, '16_posi_920': {'bp': 514979.0, 'sum': 1275978.0}, '12_posi_335': {'bp': 533563.0, 'sum': 1436068.0}, '12_posi_250': {'bp': 551742.0, 'sum': 1443461.0}, '8_posi_161': {'bp': 637068.0, 'sum': 1655214.0}, '17_posi_901': {'bp': 654627.0, 'sum': 1556154.0}, '15_posi_1090': {'bp': 410999.0, 'sum': 1115295.0}, '15_posi_101': {'bp': 533221.0, 'sum': 1445440.0}, '7_posi_374': {'bp': 571905.0, 'sum': 1433497.0}, '9_posi_1006': {'bp': 450338.0, 'sum': 1185599.0}, '12_posi_692': {'bp': 485869.0, 'sum': 1231855.0}, '9_posi_377': {'bp': 556834.0, 'sum': 1469677.0}, '6_posi_764': {'bp': 1762942.0, 'sum': 3617229.0}, 'ProcedureBlank_733': {'bp': 2059696.0, 'sum': 4324206.0}, '3_posi_761': {'bp': 1707844.0, 'sum': 3495533.0}, '4_posi_740': {'bp': 1647826.0, 'sum': 3961266.0}, '6_posi_592': {'bp': 1178356.0, 'sum': 2435419.0}, 'BLK02_61': {'bp': 859808.0, 'sum': 2179404.0}, 'ProcedureBlank_167': {'bp': 756120.0, 'sum': 1808768.0}, '1_posi_334': {'bp': 706078.0, 'sum': 1630920.0}, '1_posi_712': {'bp': 667486.0, 'sum': 1570021.0}, '7_posi_269': {'bp': 647371.0, 'sum': 1636713.0}, '13_posi_292': {'bp': 602262.0, 'sum': 1524348.0}, 'BLK02_1257': {'bp': 585184.0, 'sum': 1574058.0}, '4_posi_310': {'bp': 548789.0, 'sum': 1365681.0}, '13_posi_167': {'bp': 519510.0, 'sum': 1394983.0}, '2_posi_1488': {'bp': 506587.0, 'sum': 1279963.0}, '6_posi_1150': {'bp': 497582.0, 'sum': 1270260.0}, '1_posi_1466': {'bp': 491979.0, 'sum': 1272639.0}, '4_posi_1026': {'bp': 490158.0, 'sum': 1231728.0}, '8_posi_1153': {'bp': 448656.0, 'sum': 1186540.0}, '11_posi_981': {'bp': 431640.0, 'sum': 1194830.0}, '11_posi_1070': {'bp': 419039.0, 'sum': 1125868.0}, '7_posi_1259': {'bp': 309816.0, 'sum': 949944.0}, '1_posi_780': {'bp': 1656240.0, 'sum': 3208171.0}, 'ProcedureBlank_799': {'bp': 1469951.0, 'sum': 2828383.0}, '5_posi_731': {'bp': 1319770.0, 'sum': 3033772.0}, '6_posi_823': {'bp': 1242735.0, 'sum': 2485124.0}, 'ProcedureBlank_249': {'bp': 834631.0, 'sum': 1962132.0}, '13_posi_878': {'bp': 800442.0, 'sum': 1744821.0}, '2_posi_902': {'bp': 799693.0, 'sum': 1729920.0}, 'ProcedureBlank_353': {'bp': 760630.0, 'sum': 1820027.0}, '3_posi_373': {'bp': 668430.0, 'sum': 1632764.0}, 'ProcedureBlank_943': {'bp': 655267.0, 'sum': 1529888.0}, '4_posi_185': {'bp': 654454.0, 'sum': 1591461.0}, '2_posi_419': {'bp': 648939.0, 'sum': 1539251.0}, '3_posi_1067': {'bp': 567621.0, 'sum': 1355021.0}, '13_posi_377': {'bp': 554390.0, 'sum': 1437125.0}, '2_posi_1402': {'bp': 540027.0, 'sum': 1293221.0}, '7_posi_1425': {'bp': 414218.0, 'sum': 1114017.0}, '5_posi_1258': {'bp': 357530.0, 'sum': 1065325.0}, '15_posi_742': {'bp': 1453692.0, 'sum': 3627246.0}, 'BLK02_864': {'bp': 1340760.0, 'sum': 2712075.0}, 'ProcedureBlank_862': {'bp': 1140293.0, 'sum': 2271417.0}, 'BLK02_247': {'bp': 875931.0, 'sum': 2094264.0}, 'BLK02_417': {'bp': 864682.0, 'sum': 2052170.0}, 'BLK02_670': {'bp': 849079.0, 'sum': 1959296.0}, 'BLK02_941': {'bp': 803161.0, 'sum': 1899214.0}, 'BLK02_1133': {'bp': 712451.0, 'sum': 1795912.0}, '1_posi_417': {'bp': 636500.0, 'sum': 1567369.0}, '5_posi_1111': {'bp': 474822.0, 'sum': 1197791.0}, '5_posi_1007': {'bp': 467270.0, 'sum': 1157869.0}, '6_posi_1048': {'bp': 459269.0, 'sum': 1140471.0}, '4_posi_1446': {'bp': 418533.0, 'sum': 1114030.0}, '11_posi_1216': {'bp': 343966.0, 'sum': 969020.0}, 'ProcedureBlank_577': {'bp': 2027868.0, 'sum': 3939069.0}, '2_posi_592': {'bp': 1468133.0, 'sum': 2953712.0}, '13_posi_802': {'bp': 1241668.0, 'sum': 2490225.0}, 'BLK02_164': {'bp': 932830.0, 'sum': 2238422.0}, '6_posi_896': {'bp': 693177.0, 'sum': 1603108.0}, 'BLK02_1467': {'bp': 678176.0, 'sum': 1675531.0}, '5_posi_270': {'bp': 601941.0, 'sum': 1499241.0}, 'ProcedureBlank_1024': {'bp': 588479.0, 'sum': 1399217.0}, 'ProcedureBlank_1110': {'bp': 559476.0, 'sum': 1375631.0}, '5_posi_356': {'bp': 531749.0, 'sum': 1368394.0}, 'ProcedureBlank_1406': {'bp': 519756.0, 'sum': 1323902.0}, '2_posi_1191': {'bp': 513194.0, 'sum': 1299427.0}, '5_posi_1426': {'bp': 431909.0, 'sum': 1157112.0}, '13_posi_986': {'bp': 428644.0, 'sum': 1109727.0}, 'BLK02_801': {'bp': 2018295.0, 'sum': 3759718.0}, 'BLK02_592': {'bp': 1788036.0, 'sum': 3607306.0}, '11_posi_292': {'bp': 503821.0, 'sum': 1362479.0}, '16_posi_314': {'bp': 389695.0, 'sum': 1181458.0}}
COMMENT: RETENTION_TIME_STDEV 0.822
COMMENT: PRECURSOR_M/Z_RAW 157.144440
COMMENT: PRECURSOR_M/Z_STDEV 0.000044
COMMENT: PRECURSOR_IN_MS1 mz 157.144778; int 155.714; delta(ppm) 1.473312
COMMENT: PROPOSED_CHARGE_STATE +1; mz 158.148208; int 11.067; cor 0.939
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 189.170884; int 8.383; cor 0.895
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 198.171364; int 4.460; cor 0.883
COMMENT: PROPOSED_ION_FORM M+NH4; M+H; mz 140.118212; int 81.750; cor 0.854
COMMENT: PROPOSED_ION_FORM M+NH4; M+ACN+H; mz 181.144706; int 20.955; cor 0.865
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 198.171364; int 4.460; cor 0.883
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 198.171364; int 4.460; cor 0.883
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.032; C7H16N4; [M+H]+; delta(ppm) 0.032023
COMMENT: PROPOSED_MF SevenGoldenRules 0.058; C7H13N3; [M+NH4]+; delta(ppm) 0.057508
COMMENT: PROPOSED_MF SevenGoldenRules 0.069; C5H13N3; [M+ACN+H]+; delta(ppm) 0.069498
COMMENT: PROPOSED_MF MS-FINDER 3.163; C7H13N3; [M+NH4]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF MS-FINDER 3.020; C5H13N3; [M+ACN+H]+; delta(ppm) 105708.858196
COMMENT: PROPOSED_MF MS-FINDER 2.273; C7H16N4; [M+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS5_Sirius 40.882; C5H13N3; [M+C2H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS5_Sirius 40.882; C7H16N4; [M+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS5_Sirius 40.882; C7H13N3; [M+H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS5_Sirius 7.992; C9H18NO; [M+H]+; delta(ppm) -8.512049
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H13N3; [M+C2H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H16N4; [M+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H13N3; [M+H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS6_Sirius 59.441; C7H13N3; [M+H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS6_Sirius 59.441; C7H16N4; [M+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS6_Sirius 59.441; C5H13N3; [M+C2H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.503; C9H15O; [M+H3N+H]+; delta(ppm) -8.512049
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.503; C9H18NO; [M+H]+; delta(ppm) -8.512049
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.503; C7H15O; [M+C2H3N+H]+; delta(ppm) -8.512049
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H13N3; [M+H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H16N4; [M+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H13N3; [M+C2H3N+H]+; delta(ppm) 0.031997
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.237; ZJDIMSMQXMWMCF-UHFFFAOYSA-N; [M+NH4]+; Na,Na-Dimethylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.197; FVKFHMNJTHKMRX-UHFFFAOYSA-N; [M+NH4]+; 3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.064; QWCYKPNITLTKCK-UHFFFAOYSA-N; [M+NH4]+; 1-methyl-octahydro-1H-imidazo[4,5-c]pyridin-3-ium-2-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.064; XZDLLQQBTVSJJR-UHFFFAOYSA-N; [M+NH4]+; 1,3,5-triazaadamantane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.006; JTZKUGOOSKYHBX-UHFFFAOYSA-N; [M+NH4]+; N-alpha,N-alpha-dimethylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.987; RJWLLQWLBMJCFD-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylpiperazin-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.907; KYVBNYUBXIEUFW-UHFFFAOYSA-N; [M+ACN+H]+; 1,1,3,3-tetramethylguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FVKFHMNJTHKMRX-UHFFFAOYSA-N; [M+NH4]+; 3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KYVBNYUBXIEUFW-UHFFFAOYSA-N; [M+ACN+H]+; 1,1,3,3-tetramethylguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.987; ZJDIMSMQXMWMCF-UHFFFAOYSA-N; [M+NH4]+; Na,Na-Dimethylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.904; QWCYKPNITLTKCK-UHFFFAOYSA-N; [M+NH4]+; 1-methyl-octahydro-1H-imidazo[4,5-c]pyridin-3-ium-2-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.823; XZDLLQQBTVSJJR-UHFFFAOYSA-N; [M+NH4]+; 1,3,5-triazaadamantane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.747; RJWLLQWLBMJCFD-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylpiperazin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.738; JTZKUGOOSKYHBX-UHFFFAOYSA-N; [M+NH4]+; N-alpha,N-alpha-dimethylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.873; FVKFHMNJTHKMRX-UHFFFAOYSA-N; [M+NH4]+; 3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.725; KYVBNYUBXIEUFW-UHFFFAOYSA-N; [M+ACN+H]+; 1,1,3,3-tetramethylguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.898; ORTUYCUWCKNIND-UHFFFAOYSA-N; [M+H]+; 3-[2-(2-aminoethylamino)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.037; PBGDGOWGZQNAHJ-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)piperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.966; ZJDIMSMQXMWMCF-UHFFFAOYSA-N; [M+NH4]+; 2-(1H-imidazol-5-yl)-N,N-dimethylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.678; OSVDRMKFBHBNHF-UHFFFAOYSA-N; [M+H]+; 2-[2-(2-aminoethylamino)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.563; MVOFPBMQTXKONX-UHFFFAOYSA-N; [M+NH4]+; 3-piperazin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.517; PDDWJLGBNYUCQO-UHFFFAOYSA-N; [M+ACN+H]+; 1,1-diethylguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.501; YLFIKUFWZJZACZ-UHFFFAOYSA-N; [M+H]+; 3-[bis(2-aminoethyl)amino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.393; OCSWHADWFJTNAZ-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-2-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.336; RJWLLQWLBMJCFD-UHFFFAOYSA-N; [M+ACN+H]+; 4-methylpiperazin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.335; FJCXXLZGBXLQNN-UHFFFAOYSA-N; [M+NH4]+; 2-piperazin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.326; IMKSXUQEGCJJRT-UHFFFAOYSA-N; [M+NH4]+; cyclopropyl(4,5-dihydro-1H-imidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.317; VSYCHGCLXPSWIN-UHFFFAOYSA-N; [M+NH4]+; 1-(4,5-dihydro-1H-imidazol-2-yl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.300; VLQPUERRGYFDSR-UHFFFAOYSA-N; [M+NH4]+; 1-tert-butylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.296; HJCHYUULDNBCKE-UHFFFAOYSA-N; [M+NH4]+; 1-(2-methylpropyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.295; NDUDHWBKFFJGMA-UHFFFAOYSA-N; [M+NH4]+; 3-(2-methylimidazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.287; FXLOXQBWUPCCDL-UHFFFAOYSA-N; [M+NH4]+; 2-(3,5-dimethylpyrazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.267; JVZPYJSJSQIEOG-UHFFFAOYSA-N; [M+NH4]+; 4-imidazol-1-ylbutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.251; LIYWOKKWHOKFBA-UHFFFAOYSA-N; [M+ACN+H]+; 3-(dimethylamino)propanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.246; YCNZJCSZSWNVHU-UHFFFAOYSA-N; [M+NH4]+; 2-(4-ethylpyrazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.246; LIXGKSRWGHVUHT-UHFFFAOYSA-N; [M+NH4]+; 2-(1-ethylimidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; JUJSJFUYRXZKCK-UHFFFAOYSA-N; [M+NH4]+; 3-pyrazol-1-ylbutan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; ZPMDRIAJBDFGCZ-UHFFFAOYSA-N; [M+NH4]+; 3-imidazol-1-yl-N-methylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.225; YJGPXQPUYAAKRH-UHFFFAOYSA-N; [M+NH4]+; 2-[3-(aminomethyl)pyrrolidin-1-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.225; BBWULNDJJUENCE-UHFFFAOYSA-N; [M+NH4]+; 1-(1-ethylpyrazol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.224; CUFUZDIZPDUDPV-UHFFFAOYSA-N; [M+NH4]+; 1-(1-ethylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; OWYRGIVGRVMLAG-UHFFFAOYSA-N; [M+NH4]+; 2-(1,4-dimethylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.213; MBQAPXFDQYOMRE-UHFFFAOYSA-N; [M+NH4]+; 2-(3,5-dimethyl-1H-pyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.213; MOATUNIZJAXRFH-UHFFFAOYSA-N; [M+ACN+H]+; 5-aminopentanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.212; WODLNVYLYQXAOH-UHFFFAOYSA-N; [M+NH4]+; N-[(1-methylpyrazol-4-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.211; BSBQVAZPNNEYRF-UHFFFAOYSA-N; [M+NH4]+; 2-(4,5-dimethylimidazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.210; SRHIOMAWWIRJCB-UHFFFAOYSA-N; [M+NH4]+; 3-(4-methylpyrazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.210; RTTFXSJNRLYKMF-UHFFFAOYSA-N; [M+NH4]+; 1-(2,5-dimethylpyrazol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; CXEIEACTYOVXOR-UHFFFAOYSA-N; [M+NH4]+; 1-(2,5-dimethylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.207; NCHJUTFMHWBNCJ-UHFFFAOYSA-N; [M+NH4]+; 3-imidazol-1-ylbutan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.207; FKSKZOXOLXOIQV-UHFFFAOYSA-N; [M+NH4]+; N,N-dimethyl-1-(1-methylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.207; XSPHDDUROPJBIC-UHFFFAOYSA-N; [M+NH4]+; 3-(5-methylpyrazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.198; BYGCQGLHPCERCH-UHFFFAOYSA-N; [M+NH4]+; 3-(5-methyl-1H-pyrazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.196; IPBXAQNEXLMXRW-UHFFFAOYSA-N; [M+NH4]+; 1-(2-ethylpyrazol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.195; LNLBAJDAQVQFBD-UHFFFAOYSA-N; [M+NH4]+; 1-(1-ethylpyrazol-4-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.194; KVZSKSMTEUMSLT-UHFFFAOYSA-N; [M+NH4]+; 3-(1-methylpyrazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.194; ANFVWVAMNUWQDL-UHFFFAOYSA-N; [M+NH4]+; 4-methyl-1-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.194; PRSOTDKUNIQGKW-UHFFFAOYSA-N; [M+NH4]+; 1-(2-ethylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.194; FGIBXJBTJBRRHX-UHFFFAOYSA-N; [M+NH4]+; 2-(2-ethylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.194; OHGJHBXVKFERPR-UHFFFAOYSA-N; [M+NH4]+; 1-(5-methyl-1H-pyrazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.193; FVEXVBVWVVFGAT-UHFFFAOYSA-N; [M+NH4]+; 1-(1-ethylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.192; UKAIZVWWRMRVIH-UHFFFAOYSA-N; [M+NH4]+; 1-(1,5-dimethylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.191; GMSYNHUUHQKVSH-UHFFFAOYSA-N; [M+NH4]+; 1-(3-ethylimidazol-4-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.191; DPAINHKACVOQJW-UHFFFAOYSA-N; [M+NH4]+; 1-(1-ethylimidazol-2-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.191; BJQQCZZHUZGXKN-UHFFFAOYSA-N; [M+NH4]+; 3-(4-methylimidazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.190; GVBFGLTZOPGOSB-UHFFFAOYSA-N; [M+NH4]+; 1-(1,5-dimethylpyrazol-4-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; UFYZSPYVYKTZCA-UHFFFAOYSA-N; [M+NH4]+; 3-(1-methylpyrazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; ZHCIXQMRFVTGGF-UHFFFAOYSA-N; [M+NH4]+; 1-(1,3-dimethylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; ORGYIMPJXDYEJQ-UHFFFAOYSA-N; [M+NH4]+; 3-(5-methylimidazol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; UECWYYHRNMAMOT-UHFFFAOYSA-N; [M+NH4]+; 1-(1-methylpyrazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; HGQSWPBSWYFHEU-UHFFFAOYSA-N; [M+NH4]+; 2-(1,3-dimethylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.186; GGQSBSVBYVTPHI-UHFFFAOYSA-N; [M+NH4]+; 3-(2-methylpyrazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; SMWNYFLOMAYKKG-UHFFFAOYSA-N; [M+NH4]+; 1-(2-methylpropyl)imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; ZHBXGHWSVIBUCQ-UHFFFAOYSA-N; [M+NH4]+; 5-tert-butyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.181; MLZSYTYGLAPTKT-UHFFFAOYSA-N; [M+NH4]+; 3-(1-methylimidazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.180; ISORIIDIGILCPX-UHFFFAOYSA-N; [M+NH4]+; 1-(1-methylimidazol-2-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.178; ZGYLBJLUOKJLRB-UHFFFAOYSA-N; [M+NH4]+; 2-(4-aminopiperidin-1-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.177; XKUDYRPWUDVKEY-UHFFFAOYSA-N; [M+NH4]+; 1-(3-methylimidazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.176; IMDBGSYBIGYHOE-UHFFFAOYSA-N; [M+NH4]+; 4-(1H-imidazol-2-yl)butan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; KLEIWKYPWDZGCV-UHFFFAOYSA-N; [M+NH4]+; 5-butyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; DWVZJJWBGYDTEZ-UHFFFAOYSA-N; [M+NH4]+; (1-propan-2-ylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; DOVPROBFGXRSPX-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-2-pyrazol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; WTVUBTWCJKHMIW-UHFFFAOYSA-N; [M+NH4]+; N-methyl-2-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.116; QDBRDMCFYCUCPL-UHFFFAOYSA-N; [M+NH4]+; 5-(2-methylpropyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; LTUSECNCRNSSEB-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-4-propan-2-yl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; DEBSGISFDAOGSU-UHFFFAOYSA-N; [M+NH4]+; N-methyl-1-propan-2-ylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; BZOLWCPFLURXIV-UHFFFAOYSA-N; [M+NH4]+; (2-propylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; DRFMCJYFTZIZCG-UHFFFAOYSA-N; [M+NH4]+; N-methyl-1-propylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; NUVNGCYOZPTKQS-UHFFFAOYSA-N; [M+NH4]+; (2-propan-2-ylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; GQBHJQMCIUZWGP-UHFFFAOYSA-N; [M+NH4]+; (1,4,5-trimethylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.102; VMNKYEWGKWZUNI-UHFFFAOYSA-N; [M+NH4]+; (1-propan-2-ylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; CUBGKECWMNJUFQ-UHFFFAOYSA-N; [M+NH4]+; 2-imidazol-1-yl-2-methylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; DGVBHLRORWEBLP-UHFFFAOYSA-N; [M+NH4]+; (1,3,5-trimethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; WYHPBQDJDVJZBQ-UHFFFAOYSA-N; [M+NH4]+; (1-ethyl-5-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; KFDNTYSILYMRBA-UHFFFAOYSA-N; [M+NH4]+; N-methyl-1-(1-methylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; VEFRQAANQSZUOV-UHFFFAOYSA-N; [M+NH4]+; (1-propan-2-ylimidazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; TXMDGZMPYSPLCV-UHFFFAOYSA-N; [M+NH4]+; 1-methyl-3-propan-2-ylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; VQRRWJGAKXHHEI-UHFFFAOYSA-N; [M+NH4]+; 4,5-diethyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; ZEUDQSGLXJXOTQ-UHFFFAOYSA-N; [M+NH4]+; 2-(1-methylpyrazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; RGMVBQDEJONUNA-UHFFFAOYSA-N; [M+NH4]+; (1-ethyl-3-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; QOOHGPNLVDDARB-UHFFFAOYSA-N; [M+NH4]+; N-methyl-1-(1H-pyrazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; KGEGNOFPNKTJNU-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-5-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; UKKWVPXPYWQLFF-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-3-(1H-pyrazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.061; MBEYCURLTGQATH-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-5-propylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; SWUPMMXJWOXOTI-UHFFFAOYSA-N; [M+NH4]+; 3-methyl-1-propan-2-ylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; JWPNXAXDFINCDT-UHFFFAOYSA-N; [M+NH4]+; 4-methyl-2-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; JPUFJDDEDJUDHE-UHFFFAOYSA-N; [M+NH4]+; 1-tert-butylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; JXBWTBGYZOVCJH-UHFFFAOYSA-N; [M+NH4]+; 1-ethyl-3,5-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; IQWKFOCVXIACGA-UHFFFAOYSA-N; [M+NH4]+; (4-propan-2-yl-1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; SGUQYNMBZJPCLA-UHFFFAOYSA-N; [M+NH4]+; 1-(2-methylpropyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; PYYIDDAEMNSXFF-UHFFFAOYSA-N; [M+NH4]+; 1-(1-methylpyrazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; OJYIUVMWTPOVCN-UHFFFAOYSA-N; [M+NH4]+; 2-(1-methylpyrazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.030; IMBJNOJXJVXFSE-UHFFFAOYSA-N; [M+NH4]+; 3,5-diethyl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; OSXSDUMYPXFKCT-UHFFFAOYSA-N; [M+NH4]+; 2-(1-methylpyrazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; VVWSKQUHMPDXEV-UHFFFAOYSA-N; [M+NH4]+; 1-(1-methylpyrazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -43.712; MVOFPBMQTXKONX; [M+H3N+H]+; 1-piperazinepropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -85.770; ORTUYCUWCKNIND; [M+H]+; Diethylenetriamine, dodecyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -96.286; KYVBNYUBXIEUFW; [M+C2H3N+H]+; 1,3,3-Tetramethylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -99.509; YLFIKUFWZJZACZ; [M+H]+; 3-[bis(2-aminoethyl)amino]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -102.783; CSYYUXVOGZFCEC; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -102.985; FVKFHMNJTHKMRX; [M+H3N+H]+; Triazabicyclodecene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.210; CGWBIHLHAGNJCX; [M+C2H3N+H]+; 2-butylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.795; OSVDRMKFBHBNHF; [M+H]+; 2-[2-(2-aminoethylamino)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.231; PDDWJLGBNYUCQO; [M+C2H3N+H]+; Guanidine, diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.933; RJWLLQWLBMJCFD; [M+C2H3N+H]+; 4-methylpiperazinylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.952; LIXGKSRWGHVUHT; [M+H3N+H]+; N-ethylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.550; FXLOXQBWUPCCDL; [M+H3N+H]+; 2-(3,5-dimethylpyrazolyl)ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.167; SRHIOMAWWIRJCB; [M+H3N+H]+; 3-(4-methylpyrazolyl)propylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.809; GGQSBSVBYVTPHI; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.396; NDUDHWBKFFJGMA; [M+H3N+H]+; 3-(2-methylimidazolyl)propylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.200; UFYZSPYVYKTZCA; [M+H3N+H]+; Ambcb4002944
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.590; PRSOTDKUNIQGKW; [M+H3N+H]+; 1-(1-ethylpyrazol-5-yl)ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.308; VJSUMPPMFYQOMP; [M+H3N+H]+; Imbutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.156; IQMRCZGRXUSTNT; [M+H3N+H]+; 2-butylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.320; ZJDIMSMQXMWMCF; [M+H3N+H]+; N,N-Dimethylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.565; MBQAPXFDQYOMRE; [M+H3N+H]+; Oprea1_127554
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.185; OCSWHADWFJTNAZ; [M+H3N+H]+; 2-isopropyl-5-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.197; DGVBHLRORWEBLP; [M+H3N+H]+; (trimethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.572; CUFUZDIZPDUDPV; [M+H3N+H]+; 1-(1-ethylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.660; SGUQYNMBZJPCLA; [M+H3N+H]+; 1-(2-methylpropyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.245; OSXSDUMYPXFKCT; [M+H3N+H]+; 2-(1-methyl-1H-pyrazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.255; KGEGNOFPNKTJNU; [M+H3N+H]+; 2-methyl-5-propan-2-ylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.085; RLRXYCOJGGRMQS; [M+H3N+H]+; N''(Me),5(Me)Histamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -283.080; TXMDGZMPYSPLCV; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.366; JXBWTBGYZOVCJH; [M+H3N+H]+; 1-ethyl-3,5-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.893; QQTWSOMOTYJIQP; [M+H3N+H]+; ACMC-20chyg
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.675; PYYIDDAEMNSXFF; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.725; VLQPUERRGYFDSR; [M+H3N+H]+; 1-tert-butylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.276; OJYIUVMWTPOVCN; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.763; ZHBXGHWSVIBUCQ; [M+H3N+H]+; Oprea1_059106
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.111; GDFXUNMNTXOVGI; [M+H3N+H]+; 4-(Diethylamino)pyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -308.130; JPUFJDDEDJUDHE; [M+H3N+H]+; 1-tert-butylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.877; JTZKUGOOSKYHBX; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.328; BQWFLRWCZCMTOU; [M+H3N+H]+; Alpha-Dimethylhistane-alpha
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.507; QDBRDMCFYCUCPL; [M+H3N+H]+; Ambcb4019394
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.685; MVOFPBMQTXKONX; [M+H3N+H]+; 1-piperazinepropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.217; ORTUYCUWCKNIND; [M+H]+; Diethylenetriamine, dodecyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.149; KYVBNYUBXIEUFW; [M+C2H3N+H]+; 1,3,3-Tetramethylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.097; MVOFPBMQTXKONX; [M+H3N+H]+; 3-Piperazine-1,4-diium-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.244; KYVBNYUBXIEUFW; [M+C2H3N+H]+; 1,1,3,3-Tetramethylguanidinium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -75.650; PDDWJLGBNYUCQO; [M+C2H3N+H]+; 1,1-Diethylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.137; FVKFHMNJTHKMRX; [M+H3N+H]+; 1,3,4,6,7,8-Hexahydro-2H-pyrimido[1,2-a]pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.590; ORTUYCUWCKNIND; [M+H]+; Propanenitrile, 3-[[2-[(2-aminoethyl)amino]ethyl]amino]-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -105.957; XZDLLQQBTVSJJR; [M+H3N+H]+; 1,3,5-triazaadamantane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.599; RJWLLQWLBMJCFD; [M+C2H3N+H]+; (4-Methylpiperazin-1-yl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.875; RVBVQBYYWQSUAB; [M+C2H3N+H]+; 1,4-Diazepan-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.739; CGWBIHLHAGNJCX; [M+C2H3N+H]+; 2-Butylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.481; OSVDRMKFBHBNHF; [M+H]+; Propanenitrile, 2-[[2-[(2-aminoethyl)amino]ethyl]amino]-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -132.267; CSYYUXVOGZFCEC; [M+C2H3N+H]+; 2-Imidazolidin-4-ylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.135; YLFIKUFWZJZACZ; [M+H]+; N-(Cyanoethyl)diethylenetriamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.623; DPAINHKACVOQJW; [M+H3N+H]+; 1-(1-ethyl-1H-imidazol-2-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -166.521; ZPMDRIAJBDFGCZ; [M+H3N+H]+; [3-(1H-imidazol-1-yl)propyl](methyl)amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -187.409; NDUDHWBKFFJGMA; [M+H3N+H]+; 3-(2-Methylimidazol-1-yl)propylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.712; FKSKZOXOLXOIQV; [M+H3N+H]+; N,N-dimethyl-1-(3-methyl-1H-imidazol-3-ium-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.498; LIXGKSRWGHVUHT; [M+H3N+H]+; 2-(1-Ethyl-1h-imidazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -221.362; JVZPYJSJSQIEOG; [M+H3N+H]+; 1H-Imidazole-1-butanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -222.813; BZOLWCPFLURXIV; [M+H3N+H]+; (1-Propyl-1H-pyrazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.233; MVOFPBMQTXKONX; [M+H3N+H]+; 3-Piperazine-1,4-diium-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.162; ORTUYCUWCKNIND; [M+H]+; Propanenitrile, 3-[[2-[(2-aminoethyl)amino]ethyl]amino]-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.066; KYVBNYUBXIEUFW; [M+C2H3N+H]+; 1,1,3,3-Tetramethylguanidinium
COMMENT: CONFIDENCE Level 3: Tentative candidate, 1-piperazinepropionitrile, MVOFPBMQTXKONX-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (7); This structural isomer was suggested from the biological context HMDB HMDB0000177;
CH$NAME: 3-piperazin-1-ylpropanenitrile
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C7H13N3
CH$EXACT_MASS: 139.110947
CH$SMILES: C1CN(CCN1)CCC#N
CH$IUPAC: InChI=1S/C7H13N3/c8-2-1-5-10-6-3-9-4-7-10/h9H,1,3-7H2
CH$LINK: INCHIKEY MVOFPBMQTXKONX-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:2052050
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.453
MS$FOCUSED_ION: ION_TYPE [M+NH4]+
MS$FOCUSED_ION: PRECURSOR_M/Z 157.144778
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-3900000000-3ade7acce196900b9791
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0446444 11.0403 69.045270 1.2745 4.36 0.3910 217 f{C3H5N2}/-1.16ppm,p-C4H12N2
  70.0650305 7.2013 70.065650 1.7983 2.17 0.7012 182 f{C4H8N1}/-1.36ppm,p-C3H9N3
  71.0603868 296.9185 71.061000 0.2955 16.25 0.9869 222 f{C3H7N2}/0.17ppm,p-C4H10N2
  72.0443335 24.3337 72.044940 1.2770 10.23 -0.0070 222 ?
  72.0636336 8.8072 72.064240 1.6236 3.86 0.2455 209 ?
  85.0759508 16.3200 85.076430 1.0226 5.10 0.6784 222 f{C4H9N2}/-0.87ppm,p-C3H8N2
  86.0600533 52.5898 86.060520 0.7088 21.71 -0.1683 222 ?
  86.0712735 8.6079 86.071740 1.7776 3.67 0.2615 164 f{C3H8N3}/-0.00ppm,p-C4H9N1
  86.0792836 9.5401 86.079750 1.8704 4.30 0.0167 201 ?
  87.0552364 14.4504 87.055690 1.2291 5.93 0.2281 219 ?
  87.0633365 9.7363 87.063790 1.6425 4.12 0.1717 210 ?
  87.0917019 163.5034 87.092155 0.3559 8.72 0.9861 222 f{C4H11N2}/0.31ppm,p-C3H6N2
  111.0916444 12.5156 111.091860 1.8993 6.73 -0.0360 217 f{C6H11N2}/-0.27ppm,p-C1H6N2
  112.0392448 19.8375 112.039450 1.4191 9.90 -0.4511 221 ?
  112.0871804 10.5805 112.087385 2.1233 4.42 0.1611 210 f{C5H10N3}/2.29ppm,p-C2H7N1
  112.0948654 11.0564 112.095070 1.7931 5.26 -0.0432 215 ?
  113.0708864 14.7715 113.071080 1.3089 6.12 0.2241 221 ?
  114.0663177 10.1764 114.066500 1.9813 4.14 0.0749 195 ?
  114.1025982 121.5805 114.102780 0.4382 7.78 0.9773 222 f{C5H12N3}/0.21ppm,p-C2H5N1
  129.0658766 21.3140 129.065860 1.4334 10.50 -0.4244 220 ?
  129.1023272 30.5243 129.102310 1.5724 18.38 -0.2130 222 ?
  139.0976751 12.3576 139.097580 1.9626 5.59 -0.1725 215 f{C6H11N4}/-1.06ppm,p-C1H6
  140.0454157 20.0294 140.045320 1.7637 9.95 -0.3261 215 ?
  140.0808157 43.2932 140.080720 2.4843 17.44 0.0101 217 ?
  140.0913307 27.1980 140.091235 4.1687 14.79 -0.5858 222 ?
  157.0612067 64.8267 157.061100 1.8209 28.84 -0.4302 214 ?
  157.0973067 211.2858 157.097200 0.7893 86.96 0.8780 222 ?
  157.1085668 44.5794 157.108460 1.4449 15.64 0.2428 205 ?
  157.1447868 999.0000 157.144680 0.2736 0.00 1.0000 222 f{C7H17N4}/0.09ppm,p
PK$NUM_PEAK: 29
PK$PEAK: m/z int. rel.int.
  69.044644 11.04 11
  70.065030 7.20 7
  71.060387 296.92 296
  72.044333 24.33 24
  72.063634 8.81 8
  85.075951 16.32 16
  86.060053 52.59 52
  86.071273 8.61 8
  86.079284 9.54 9
  87.055236 14.45 14
  87.063337 9.74 9
  87.091702 163.50 163
  111.091644 12.52 12
  112.039245 19.84 19
  112.087180 10.58 10
  112.094865 11.06 11
  113.070886 14.77 14
  114.066318 10.18 10
  114.102598 121.58 121
  129.065877 21.31 21
  129.102327 30.52 30
  139.097675 12.36 12
  140.045416 20.03 20
  140.080816 43.29 43
  140.091331 27.20 27
  157.061207 64.83 64
  157.097307 211.29 211
  157.108567 44.58 44
  157.144787 999.00 999
//
